| # | Title | Journal | Year | Citations |
|---|
| 1 | Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1 | Lancet, The | 1994 | 525 |
| 2 | The phenotype and fate of the antibody-forming cells of the splenic foci | European Journal of Immunology | 1996 | 315 |
| 3 | SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis. | Journal of Clinical Investigation | 1988 | 292 |
| 4 | A Randomized, Multicenter Study of Steroid Avoidance, Early Steroid Withdrawal or Standard Steroid Therapy in Kidney Transplant Recipients | American Journal of Transplantation | 2008 | 274 |
| 5 | The Effect of Protein Restriction on the Progression of Renal Insufficiency | New England Journal of Medicine | 1989 | 267 |
| 6 | Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study | Journal of Medical Genetics | 2017 | 262 |
| 7 | Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-α | Atherosclerosis | 2016 | 188 |
| 8 | Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice | International Journal of Biochemistry and Cell Biology | 1997 | 178 |
| 9 | Double-Blind, Placebo-Controlled Study on the Effect of the Aldosterone Receptor Antagonist Spironolactone in Patients Who Have Persistent Proteinuria and Are on Long-Term Angiotensin-Converting Enzyme Inhibitor Therapy, with or without an Angiotensin II Receptor Blocker | Clinical Journal of the American Society of Nephrology: CJASN | 2006 | 178 |
| 10 | Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease | Lancet, The | 1992 | 175 |
| 11 | Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO) | Kidney International | 2006 | 173 |
| 12 | Suppression of the humoral immune response by mycophenolate mofetil | Nephrology Dialysis Transplantation | 1998 | 169 |
| 13 | Hypoxia and Hypoxia Signaling in Tissue Repair and Fibrosis | International Review of Cell and Molecular Biology | 2012 | 158 |
| 14 | Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease? | Kidney International | 2013 | 155 |
| 15 | Ischemic acute renal failure: Long-term histology of cell and matrix changes in the rat | Kidney International | 2000 | 150 |
| 16 | Hypoxia in tissue repair and fibrosis | Cell and Tissue Research | 2016 | 144 |
| 17 | Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt‐induced hypertension in mice | British Journal of Pharmacology | 2016 | 143 |
| 18 | HÆMATURIA: GLOMERULAR OR NON-GLOMERULAR? | Lancet, The | 1979 | 137 |
| 19 | Pressor responsiveness in corticosteroid-induced hypertension in humans. | Hypertension | 1992 | 131 |
| 20 | The hypertensive effect of synthetic glucocorticoids in man: role of sodium and volume | Journal of Hypertension | 1989 | 119 |
| 21 | HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome | Journal of the American Society of Nephrology: JASN | 2015 | 118 |
| 22 | Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO) | Kidney International | 2008 | 115 |
| 23 | Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists | Journal of Clinical Periodontology | 1993 | 114 |
| 24 | DETERIORATION IN RENAL FUNCTION IN ASSOCIATION WITH CO-TRIMOXAZOLE THERAPY | Lancet, The | 1973 | 108 |
| 25 | Anti‐fibrotic actions of relaxin | British Journal of Pharmacology | 2017 | 107 |
| 26 | Macroscopic hematuria in mesangial IgA nephropathy: Correlation with glomerular crescents and renal dysfunction | Kidney International | 1983 | 101 |
| 27 | Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis | Kidney International | 2014 | 98 |
| 28 | Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro | Nephrology Dialysis Transplantation | 2004 | 97 |
| 29 | Accelerated Progression of Calcific Aortic Stenosis in Dialysis Patients | Nephron Clinical Practice | 2003 | 95 |
| 30 | Interstitial Myofibroblasts in IgA Glomerulonephritis | American Journal of Nephrology | 1995 | 94 |
| 31 | Treatment of IgA nephropathy with eicosapentanoic acid (EPA): a two-year prospective trial | Clinical Nephrology | 1989 | 94 |
| 32 | Successful ABO-Incompatible Kidney Transplantation with Antibody Removal and Standard Immunosuppression | American Journal of Transplantation | 2011 | 93 |
| 33 | Renal dialysis abatement: lessons from a social study | Palliative Medicine | 2005 | 91 |
| 34 | Green nephrology | Nature Reviews Nephrology | 2020 | 91 |
| 35 | Pharmacokinetic studies of dalteparin (Fragmin), enoxaparin (Clexane), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients | American Journal of Kidney Diseases | 2002 | 87 |
| 36 | Drugs of the future: the hormone relaxin | Cellular and Molecular Life Sciences | 2007 | 84 |
| 37 | IMPACT OF ACUTE REJECTION THERAPY ON INFECTIONS AND MALIGNANCIES IN RENAL TRANSPLANT RECIPIENTS | Transplantation | 1999 | 81 |
| 38 | Participation of intravascular coagulation in the pathogenesis of glomerular and vascular lesions | Kidney International | 1975 | 80 |
| 39 | Interstitial Myof ibroblasts in Experimental Renal Infection and Scarring | American Journal of Nephrology | 1995 | 77 |
| 40 | Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry Registry | Genetics in Medicine | 2013 | 74 |
| 41 | Exercise Performance Falls over Time in Patients with Chronic Kidney Disease Despite Maintenance of Hemoglobin Concentration | Clinical Journal of the American Society of Nephrology: CJASN | 2006 | 72 |
| 42 | Renal biopsy: indications and complications in pregnancy | BJOG: an International Journal of Obstetrics and Gynaecology | 1987 | 71 |
| 43 | Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study | Molecular Genetics & Genomic Medicine | 2018 | 70 |
| 44 | A Phase 2 study of migalastat hydrochloride in females with Fabry disease: Selection of population, safety and pharmacodynamic effects | Molecular Genetics and Metabolism | 2013 | 69 |
| 45 | Reflux Nephropathy and Chronic Atrophic Pyelonephritis: A Review | Journal of Infectious Diseases | 1978 | 64 |
| 46 | Renal biopsy as an outpatient procedure | American Journal of Kidney Diseases | 1995 | 64 |
| 47 | Anti-neutrophil cytoplasm antibodies in rheumatoid arthritis | Clinical and Experimental Immunology | 2008 | 63 |
| 48 | Fibrosis in the kidney: is a problem shared a problem halved? | Fibrogenesis and Tissue Repair | 2012 | 63 |
| 49 | Focal Segmental Glomerulosclerosis in Patients with Mandibuloacral Dysplasia Owing to ZMPSTE24 Deficiency | Journal of Investigative Medicine | 2006 | 60 |
| 50 | The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial | Clinical Nephrology | 1990 | 60 |
